GSK Settlement: Changing The Way Drug Cos. Do Business?

Law360, New York (July 12, 2012, 1:52 PM ET) -- On July 2, 2012, the U.S. Department of Justice announced the largest health care fraud settlement in U.S. history: GlaxoSmithKline LLC  will pay $3 billion to resolve criminal and civil allegations of unlawfully promoting prescription drugs, failing to report safety data and engaging in allegedly false price reporting practices. This resolution includes a criminal fine and forfeiture totaling $1 billion and $2 billion in civil payments.

Historically Severe Criminal and Civil Fines

Under the Food, Drug and Cosmetic Act (“FDCA”), GSK may promote its prescription drugs...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required